HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability

Conclusions
HBsAg seroclearance achieved after NUC treatment was associated with favourable clinical outcomes and was durable in most cases during long-term follow-up.

Source: Gut - July 8, 2014 Category: Gastroenterology Authors: Kim, G.-A., Lim, Y.-S., An, J., Lee, D., Shim, J. H., Kim, K. M., Lee, H. C., Chung, Y.-H., Lee, Y. S., Suh, D. J. Tags: Hepatitis B, Hepatic cancer Hepatology Source Type: research